We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
(+4.1%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$94.2M |
| 2 |
Medtronic
MDT
|
+$83.5M |
| 3 |
Verizon
VZ
|
+$54.1M |
| 4 |
Adobe
ADBE
|
+$54.1M |
| 5 |
Amazon
AMZN
|
+$50.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$81.3M |
| 2 |
Sensata Technologies
ST
|
+$78M |
| 3 |
PG&E
PCG
|
+$52M |
| 4 |
Amgen
AMGN
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 11.2% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
State Street
STT
$50.9B
| $6.71M | 0.03% |
72,128
-75,548
| -51% | -$7.49M |
|
552
Hershey
HSY
$34.2B
| $6.69M | 0.03% |
71,903
+4,103
| +6% | +$383K |
|
553
Federated Hermes
FHI
$4.35B
| $6.66M | 0.03% |
285,600
+61,700
| +28% | +$1.65M |
|
554
TherapeuticsMD
TXMD
$25M
| $6.63M | 0.03% |
21,241
| – | – |
|
555
Halozyme
HALO
$12.1B
| $6.6M | 0.03% |
+391,109
| New | +$7.39M |
|
556
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $6.54M | 0.03% |
155,000
+14,800
| +11% | +$668K |
|
|
TSRO
557
DELISTED
TESARO, Inc.
TSRO
| $6.51M | 0.03% |
146,419
+1,728
| +1% | +$83.9K |
|
|
ESRX
558
DELISTED
Express Scripts Holding Company
ESRX
| $6.5M | 0.02% |
84,227
-503
| -0.6% | -$37.7K |
|
559
Silicon Motion
SIMO
$8.11B
| $6.5M | 0.02% |
122,821
-76,003
| -38% | -$3.73M |
|
560
Franco-Nevada
FNV
$50.7B
| $6.49M | 0.02% |
88,840
+25,933
| +41% | +$1.84M |
|
|
CLDR
561
DELISTED
Cloudera, Inc.
CLDR
| $6.39M | 0.02% |
468,645
+73,422
| +19% | +$1.12M |
|
562
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.8B
| $6.38M | 0.02% |
47,500
-3,500
| -7% | -$465K |
|
563
Kraft Heinz
KHC
$29.3B
| $6.37M | 0.02% |
101,337
-66,534
| -40% | -$3.95M |
|
564
Enbridge
ENB
$106B
| $6.36M | 0.02% |
178,269
-435
| -0.2% | -$13.8K |
|
565
Twilio
TWLO
$37.2B
| $6.35M | 0.02% |
113,418
+28,797
| +34% | +$1.43M |
|
|
XLRN
566
DELISTED
Acceleron Pharma
XLRN
| $6.31M | 0.02% |
130,055
-103,449
| -44% | -$3.77M |
|
567
Vishay Intertechnology
VSH
$4.82B
| $6.29M | 0.02% |
271,282
-275,708
| -50% | -$5.75M |
|
568
Service Corp International
SCI
$11.1B
| $6.29M | 0.02% |
175,751
+15,819
| +10% | +$586K |
|
569
BCE
BCE
$21.4B
| $6.28M | 0.02% |
155,001
-33,500
| -18% | -$1.41M |
|
570
Expeditors International
EXPD
$25.2B
| $6.27M | 0.02% |
85,753
+37,908
| +79% | +$2.65M |
|
571
Enova International
ENVA
$4.32B
| $6.26M | 0.02% |
171,400
-32,800
| -16% | -$998K |
|
572
Allstate
ALL
$65B
| $6.26M | 0.02% |
68,539
+8,339
| +14% | +$793K |
|
|
SYKE
573
DELISTED
SYKES Enterprises Inc
SYKE
| $6.22M | 0.02% |
216,300
| – | – |
|
|
OXFD
574
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $6.19M | 0.02% |
479,975
-100,639
| -17% | -$1.36M |
|
575
iShares Core US Aggregate Bond ETF
AGG
$137B
| $6.18M | 0.02% |
58,160
+26,000
| +81% | +$2.76M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2018 Portfolio in Review
As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
- Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
- Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
- Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
- Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
- Axa opened 112 new positions and closed 130 in Q2 2018.
- Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.
Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.